Rituximab, interferon‐alfa‐2b and dose dense<scp>CVP</scp>is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the<scp>LNH</scp>‐<scp>PRO</scp>‐05 study
In: British Journal of Haematology, Jg. 186 (2019-01-17), S. 168-170
Online
unknown
Zugriff:
Titel: |
Rituximab, interferon‐alfa‐2b and dose dense<scp>CVP</scp>is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the<scp>LNH</scp>‐<scp>PRO</scp>‐05 study
|
---|---|
Autor/in / Beteiligte Person: | Nicolás, Concepción ; García-Noblejas, Ana ; López-Jiménez, Javier ; Maria José Requena ; Cannata-Ortiz, Jimena ; Arranz, Reyes ; Concepción Alaez Uson |
Link: | |
Zeitschrift: | British Journal of Haematology, Jg. 186 (2019-01-17), S. 168-170 |
Veröffentlichung: | Wiley, 2019 |
Medientyp: | unknown |
ISSN: | 1365-2141 (print) ; 0007-1048 (print) |
DOI: | 10.1111/bjh.15760 |
Schlagwort: |
|
Sonstiges: |
|